Literature DB >> 15194645

Leptin receptor expression on T lymphocytes modulates chronic intestinal inflammation in mice.

B Siegmund1, J A Sennello, J Jones-Carson, F Gamboni-Robertson, H A Lehr, A Batra, I Fedke, M Zeitz, G Fantuzzi.   

Abstract

BACKGROUND: Leptin regulates appetite through the long isoform of its receptor in the hypothalamus. Although leptin regulates immune responses, it is still unknown whether a direct effect of leptin on lymphocytes is required. AIMS: To clarify whether expression of leptin receptors on T lymphocytes modulates intestinal inflammation in mice.
METHODS: The model of colitis induced by transfer of CD4(+)CD45RB(high) (RB(high)) cells into scid mice was used. Wild-type (WT) or leptin receptor deficient (db/db) RB(high) cells were transferred into scid mice and development of colitis evaluated.
RESULTS: Leptin receptors were expressed on both RB(high) and RB(low) cells. Intestinal lymphocytes of mice with colitis expressed high leptin levels compared with healthy controls whereas the opposite was true for serum leptin levels. Transfer of RB(high) cells from db/db mice induced delayed disease compared with transfer of WT cells. A high rate of apoptosis in lamina propria lymphocytes and reduced cytokine production were observed early on in scid mice receiving db/db RB(high) cells. These effects were not due to the high levels of glucocorticoids present in db/db mice as administration of corticosterone to WT mice failed to reproduce this phenomenon. High expression of peroxisome proliferator activated receptor gamma was observed in the colon of recipients of db/db compared with WT cells. Freshly isolated db/db RB(high) cells produced low levels of interferon gamma. Despite delayed onset of colitis, as disease progressed differences between mice receiving WT or db/db cells were no longer apparent.
CONCLUSIONS: These results suggest that leptin affects the immune response, partly by acting on the long isoform of its receptor expressed on T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194645      PMCID: PMC1774108          DOI: 10.1136/gut.2003.027136

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

1.  A novel transcription factor, T-bet, directs Th1 lineage commitment.

Authors:  S J Szabo; S T Kim; G L Costa; X Zhang; C G Fathman; L H Glimcher
Journal:  Cell       Date:  2000-03-17       Impact factor: 41.582

2.  Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production.

Authors:  B Siegmund; G Fantuzzi; F Rieder; F Gamboni-Robertson; H A Lehr; G Hartmann; C A Dinarello; S Endres; A Eigler
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-10       Impact factor: 3.619

3.  PPARgamma and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's disease.

Authors:  K Wada; A Nakajima; R S Blumberg
Journal:  Trends Mol Med       Date:  2001-08       Impact factor: 11.951

4.  Requirement for leptin in the induction and progression of autoimmune encephalomyelitis.

Authors:  G Matarese; A Di Giacomo; V Sanna; G M Lord; J K Howard; A Di Tuoro; S R Bloom; R I Lechler; S Zappacosta; S Fontana
Journal:  J Immunol       Date:  2001-05-15       Impact factor: 5.422

5.  Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure.

Authors:  V Y Melnikov; T Ecder; G Fantuzzi; B Siegmund; M S Lucia; C A Dinarello; R W Schrier; C L Edelstein
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

Review 6.  Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question.

Authors:  M F Neurath; S Finotto; I Fuss; M Boirivant; P R Galle; W Strober
Journal:  Trends Immunol       Date:  2001-01       Impact factor: 16.687

7.  Human leptin enhances activation and proliferation of human circulating T lymphocytes.

Authors:  C Martín-Romero; J Santos-Alvarez; R Goberna; V Sánchez-Margalet
Journal:  Cell Immunol       Date:  2000-01-10       Impact factor: 4.868

Review 8.  Leptin in the regulation of immunity, inflammation, and hematopoiesis.

Authors:  G Fantuzzi; R Faggioni
Journal:  J Leukoc Biol       Date:  2000-10       Impact factor: 4.962

9.  High-dose leptin activates human leukocytes via receptor expression on monocytes.

Authors:  H Zarkesh-Esfahani; G Pockley; R A Metcalfe; M Bidlingmaier; Z Wu; A Ajami; A P Weetman; C J Strasburger; R J Ross
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

10.  Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18.

Authors:  R Faggioni; J Jones-Carson; D A Reed; C A Dinarello; K R Feingold; C Grunfeld; G Fantuzzi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 12.779

View more
  35 in total

Review 1.  Adipose tissue and inflammatory bowel disease pathogenesis.

Authors:  Christopher Fink; Iordanes Karagiannides; Kyriaki Bakirtzi; Charalabos Pothoulakis
Journal:  Inflamm Bowel Dis       Date:  2012-03-08       Impact factor: 5.325

2.  Leptin in intestinal inflammation: good and bad gut feelings.

Authors:  G Matarese; R I Lechler
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

Review 3.  Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?

Authors:  Laurent Peyrin-Biroulet; Mathias Chamaillard; Florent Gonzalez; Elodie Beclin; Cecilia Decourcelle; Laurent Antunes; Jérôme Gay; Christel Neut; Jean-Frédéric Colombel; Pierre Desreumaux
Journal:  Gut       Date:  2006-09-06       Impact factor: 23.059

Review 4.  Extraluminal factors contributing to inflammatory bowel disease.

Authors:  Arvind Batra; Thorsten Stroh; Britta Siegmund
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

5.  T cell-derived leptin contributes to increased frequency of T helper type 17 cells in female patients with Hashimoto's thyroiditis.

Authors:  S Wang; S E Baidoo; Y Liu; C Zhu; J Tian; J Ma; J Tong; J Chen; X Tang; H Xu; L Lu
Journal:  Clin Exp Immunol       Date:  2013-01       Impact factor: 4.330

Review 6.  Neuropeptides, mesenteric fat, and intestinal inflammation.

Authors:  Iordanes Karagiannides; Charalabos Pothoulakis
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

Review 7.  Three questions about leptin and immunity.

Authors:  Giamila Fantuzzi
Journal:  Brain Behav Immun       Date:  2008-10-25       Impact factor: 7.217

8.  Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patients.

Authors:  Martin H Holtmann; Frank Krummenauer; Christina Claas; Kristina Kremeyer; Dirk Lorenz; Olivia Rainer; Iris Vogel; Ulrich Böcker; Stephan Böhm; Carsten Büning; Rainer Duchmann; Guido Gerken; Hans Herfarth; Norbert Lügering; Wolfgang Kruis; Max Reinshagen; Jan Schmidt; Andreas Stallmach; Jürgen Stein; Andreas Sturm; Peter R Galle; Daan W Hommes; Geert D'Haens; Paul Rutgeerts; Markus F Neurath
Journal:  Dig Dis Sci       Date:  2009-06-10       Impact factor: 3.199

9.  Role of leptin receptor-induced STAT3 signaling in modulation of intestinal and hepatic inflammation in mice.

Authors:  Melissa E Gove; Davina H Rhodes; Maria Pini; Jantine W van Baal; Joseph A Sennello; Raja Fayad; Robert J Cabay; Martin G Myers; Giamila Fantuzzi
Journal:  J Leukoc Biol       Date:  2008-12-03       Impact factor: 4.962

Review 10.  Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review.

Authors:  John N Fain
Journal:  Mediators Inflamm       Date:  2010-05-23       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.